Please login to the form below

Not currently logged in
Email:
Password:

product launches

This page shows the latest product launches news and features for those working in and with pharma, biotech and healthcare.

Novo bolstered by new diabetes, obesity products

Novo bolstered by new diabetes, obesity products

It is the first oral alternative to injectable GLP-1 agonists, and has also been touted by Novo as a potential blockbuster product. ... While Novo has traditionally relied on its US insulin for much of its revenues, its new product launches have offset

Latest news

More from news
Approximately 0 fully matching, plus 125 partially matching documents found.

Latest Intelligence

  • Pharmaceutical innovation in the APAC region Pharmaceutical innovation in the APAC region

    The correlation between each of the three indices is less pronounced in this tier (many on the list have yet to bring a product to market or expand internationally). ... increase. In particular, Mainland China’s heavy investment in cancer therapies

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    PME talks to its European leader Theresa Heggie. Even as it launches its first ever product Onpattro, Alnylam is already a biotech industry case study. ... and sustainable clinical pipeline and a robust product engine by the end of 2020; a company

  • Positive disruption in business intelligence Positive disruption in business intelligence

    During the years before a product launches, HCP ‘digital opinion leaders’ - online HCP influencers in a particular therapy area - may be identified who are advocating for a new product in development. ... Tactical opportunities. Listening to HCPs’

  • Beyond the annual plan Beyond the annual plan

    In the last five years, the pharmaceutical industry has shifted from blockbusters in primary care to an increased number of high value specialty launches. ... This means more product launches in more indications, marketed to larger audiences than ever

  • ‘Dear Pharma, stop talking, start delivering’ ‘Dear Pharma, stop talking, start delivering’

    Hence, the resulting services and apps cater to one specific product or perhaps one disease. ... Reap the launch opportunity: Product launches allow leveraging global resources for developing an effective and globally scalable engagement programme.

More from intelligence
Approximately 0 fully matching, plus 16 partially matching documents found.

Latest appointments

  • Novo Nordisk target Ablynx reshuffles its board Novo Nordisk target Ablynx reshuffles its board

    Hensen is the ideal person to lead the board moving forward and his wealth of experience is particularly relevant as we advance towards the potential approvals and global launches of our ... lead, wholly-owned product, caplacizumab, in addition to

  • Astellas promotes John Demaree Astellas promotes John Demaree

    In his new role, Demaree will lead the promotion of in-market products, the preparation of product launches and will collaborate with Astellas' partner organisations in the region on marketing strategy.

  • The Medicines Company appoints Biogen's Tony Kingsley The Medicines Company appoints Biogen's Tony Kingsley

    Kingsley previously served as Biogen's executive vice president, global commercial operations, where the product launches he oversaw included the multiple sclerosis blockbuster Tecfidera (dimethyl fumerate).

  • Coloplast appoints new learning and development manager Coloplast appoints new learning and development manager

    Michelle has over 17 years of experience in training and development which involved systems training, training for new hires and product launches.

  • Nabriva Therapeutics adds Will Sargent to team Nabriva Therapeutics adds Will Sargent to team

    Sargent has over twenty years of experience in the biopharmaceutical industry, including multiple product and line extension launches. ... Nabriva is currently moving rapidly to advance its lead product, lefamulin, into phase III clinical studies which

More from appointments
Approximately 0 fully matching, plus 13 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 49 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...

Infographics